Atria Wealth Solutions’s Direxion HCM Tactical Enhanced US ETF HCMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$445K Sell
13,641
-31,613
-70% -$902K 0.01% 969
2025
Q1
$1.37M Sell
45,254
-79,981
-64% -$2.83M 0.02% 770
2024
Q4
$4.52M Buy
125,235
+92,598
+284% +$3.41M 0.05% 382
2024
Q3
$1.15M Buy
32,637
+2,258
+7% +$75.5K 0.01% 862
2024
Q2
$1.04M Sell
30,379
-150
-0.5% -$4.64K 0.01% 884
2024
Q1
$945K Buy
30,529
+768
+3% +$22.1K 0.01% 934
2023
Q4
$793K Buy
29,761
+14,188
+91% +$348K 0.01% 977
2023
Q3
$370K Sell
15,573
-184
-1% -$4.74K 0.01% 1285
2023
Q2
$409K Buy
+15,757
New +$397K 0.01% 1251

Other funds holding HCMT

Atria Wealth Solutions's HCMT Position: Q2 2025 in Review

Atria Wealth Solutions reduced its Direxion HCM Tactical Enhanced US ETF (HCMT) stake by 70% in Q2 2025, selling an estimated $902K and leaving 13,641 shares worth $445K. The position accounts for 0.01% of the portfolio, ranked #969.

Atria Wealth Solutions first reported a position in HCMT in Q2 2023 and has held it in 9 quarters since. The position peaked at $4.52M in Q4 2024. 39 funds tracked by Wall St. Rank hold HCMT as of Q2 2025.

  • Atria Wealth Solutions held 13,641 shares of Direxion HCM Tactical Enhanced US ETF worth $445K as of Q2 2025.
  • Atria Wealth Solutions sold 31,613 Direxion HCM Tactical Enhanced US ETF shares in Q2 2025, an estimated $902K.
  • Direxion HCM Tactical Enhanced US ETF made up 0.01% of Atria Wealth Solutions's portfolio in Q2 2025, its #969 holding.
  • Atria Wealth Solutions first reported a position in Direxion HCM Tactical Enhanced US ETF in Q2 2023 and has held it in 9 quarters since.
  • Atria Wealth Solutions's Direxion HCM Tactical Enhanced US ETF position peaked at $4.52M in Q4 2024.
  • 39 funds tracked by Wall St. Rank held Direxion HCM Tactical Enhanced US ETF as of Q2 2025.

Based on Atria Wealth Solutions's 13F filing for Q2 2025, filed 25 Jul 2025.